Rotarix
NDC 58160-740, Rotavirus Vaccine, Live, Oral, solution, from GlaxoSmithKline Biologicals SA.
- Product NDC
- 58160-740
- Status
- Listed
- Labeler
- GlaxoSmithKline Biologicals SA
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125265
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58160-740 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HUMAN ROTAVIRUS A TYPE G1P(8) STRAIN RIX4414 LIVE ANTIGEN1000 [CCID_50]/mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Live Attenuated Rotavirus Vaccine [EPC]; Rotavirus Vaccines [CS]; Vaccines, Attenuated [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58160-740-21 | 58160074021 | 10 APPLICATOR in 1 CARTON (58160-740-21) / 1.5 mL in 1 APPLICATOR (58160-740-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 58160-740 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58160-740 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58160-740. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.